Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies - Astellas Pharma (OTC:ALPMY)

- Focuses on digitizing cell manufacturing processes through robotics technology TOKYO, May 21, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced

Related Keywords

Tokyo ,Japan ,Naoki Okamura ,Astellas Pharma Inc ,Safety Of Products Including Pharmaceuticals ,Robotic Biology Institute ,Prnewswire Astellas Pharma Inc ,Medical Device ,Astellas Pharma ,Cell Therapy Platform Combining Robotics ,Medical Device Act ,Securing Quality ,Products Including Pharmaceuticals ,Focus Area Approach ,